Tuesday Dec 1 | The Biotech Stock Blog
Somaxon Pharmaceuticals: FDA Close to a Decision for Silenor
The FDA will complete its review and provide an action letter to Somaxon Pharmaceuticals relating to the Silenor NDA by December 4, 2009.
Sex, Drugs, and the Rocky Economy: Drugs
Asked to name the most recession-resistant commodities, most people would place "drugs" in the top spot.
Orchid receives USFDA approval for Zaleplon capsules
Orchid Chemicals & Pharmaceuticals has received approval from the US Food and Drug Administration for its abbreviated new drug application for Zaleplon capsules, 5mg and 10mg.
Natco Pharma launches anti-swine flu medicine
Drug maker Natco Pharma Friday said it has launched anti-swine flu drug Natflu. The maximum retail price of the medicine is fixed at Rs.480 for a bottle of 10 capsules and is available in all licensed pharmacies, the company said in a regulatory statement.
Presented at SLEEP 2009: New Controlled-Release Formulations of...
Jun 8, 2009 - Research sponsored by Somnus Therapeutics, Inc. demonstrates that new controlled-release formulations of a marketed insomnia medication have shown a pharmacodynamic profile indicative of a potential therapy that could address a frequent complaint of insomnia sufferers: preventing middle-of-the-night awakening without next-morning ...
A Cost-Effective Good Night's Sleep
How much would you pay for a good night's sleep? If the sleep peddlers have their way, quite a bit.
Also on Topix